ULURU INC. 8-K 2007
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 13, 2007
Registrant’s telephone number, including area code: (214) 905-5145
- 1 -
TABLE OF CONTENTS
- 2 -
Effective August 13, 2007, the Board of Directors of ULURU Inc. (the “Company”) appointed W. Anthony Vernon to serve as a director of the Company.
Mr. Vernon currently serves as a director of several consumer, biotech and medical device companies, to include Medivation Inc., NovoCure Ltd., Cord Blood Registry, and Disc Dynamics Inc. He has previously held the positions of Company Group Chairman with DePuy Orthopedics, President of Centocor, Inc. and McNeil Consumer Healthcare. Prior to these positions, Tony was Worldwide President of the Johnson & Johnson / Merck joint venture.
The information in Item 5.02 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 5.02 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any incorporation by reference language in any such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
- 3 -
- 4 -